Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.1000 (0.86%) ($40.3000 - $42.4000) on Fri. Sep. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 67 | Latest Price | $41.1000(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.495% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $40.58(1.28%) | 10 Day Moving Average | $40.21(2.21%) | 20 Day Moving Average | $39.34(4.47%) | To recent high | -12.4% | To recent low | 17.3% | Market Cap | $3.054b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |